EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Artificial intelligence across the aging continuum: Mechanistic geroscience, therapeutic innovation, and clinical impact

Hongbo Li, Peace Osebhue Abhulimen, Qiuliyang Yu, Wenxiang Cheng, Lucy Wanjiru Njunge

Ageing Research Reviews · 2026

DOI: 10.1016/j.arr.2026.103205 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Ageing Research Reviews, 2026. Verfasst von Hongbo Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Medicine, HuanKui Academy, Nanchang University, Nanchang, China. Hauptthemen laut MEDLINE: Aging, Artificial Intelligence, Geroscience, Translational Research, Biomedical. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 247 Literaturangaben. Gefördert von: Department of Education of Guangdong Province, National Natural Science Foundation of China, Basic and Applied Basic Research Foundation of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aging emerges from nonlinear interactions among primary, antagonistic, and integrative hallmarks that progressively erode tissue resilience. As global demographics shift and chronic disease burden intensifies, extending healthspan with mechanistic precision has become imperative, accelerating the incorporation of artificial intelligence into geroscience. AI leverages multi-omics, spatial biology, imaging, and clinical data to reveal nonlinear structures linking hallmark interactions to tissue vulnerability and organismal decline. These mechanistic insights inform target prioritization, perturbation-based pathway modeling, and rational design of multi-target geroprotectors, including compounds already advancing through clinical trials. Beyond discovery, AI supports synthetic data generation, cross-disease repurposing, and personalized geriatric care through digital phenotyping and predictive analytics. However, these advances hinge on confronting fundamental challenges in data quality, confounding variables, batch effects, and technical artifacts that risk encoding spurious correlations, necessitating hierarchical experimental validation and explainable AI to distinguish causal mechanisms from epiphenomena. Algorithmic bias, digital ageism, privacy vulnerabilities, and infrastructural inequalities further threaten to exacerbate disparities among vulnerable aging populations. This review uniquely traces AI across the complete translational continuum, from hallmark-grounded biomarker discovery to clinical deployment, while positioning validation rigor and ethical infrastructure as core scientific determinants of a transformative AI-geroscience ecosystem.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AgingArtificial IntelligenceGeroscienceTranslational Research, BiomedicalHumansBiomarkers

Stichwörter der Autor:innen

Artificial IntelligenceBiological AgingBiomarker and Drug DiscoveryClinical InterventionGeriatric HealthcareGeroscience

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Clinical Medicine, HuanKui Academy, Nanchang University, Nanchang, China.
  • China-Europe Research Ecosystem for Advanced Therapeutics Enterprise, Institute of Biomedicine and Biotechnology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.
  • China-Europe Research Ecosystem for Advanced Therapeutics Enterprise, Institute of Biomedicine and Biotechnology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China. Electronic addre…
  • Translational Medicine R&D Center, Institute of Biomedical and Health Engineering, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China. Electronic address: wx.cheng@siat.ac.cn.

Förderung

  • Department of Education of Guangdong Province
  • National Natural Science Foundation of China
  • Basic and Applied Basic Research Foundation of Guangdong Province
  • Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences
  • Shenzhen Science and Technology Innovation Program

Zitieren

APA

Li, H., Abhulimen, P. O., Yu, Q., Cheng, W., & Njunge, L. W. (2026). Artificial intelligence across the aging continuum: Mechanistic geroscience, therapeutic innovation, and clinical impact. Ageing Research Reviews. https://doi.org/10.1016/j.arr.2026.103205

Vancouver

Li H, Abhulimen PO, Yu Q, Cheng W, Njunge LW. Artificial intelligence across the aging continuum: Mechanistic geroscience, therapeutic innovation, and clinical impact. Ageing Research Reviews. 2026. doi:10.1016/j.arr.2026.103205

BibTeX
@article{Li2026,
  author = {Li, Hongbo and Abhulimen, Peace Osebhue and Yu, Qiuliyang and Cheng, Wenxiang and Njunge, Lucy Wanjiru},
  title = {Artificial intelligence across the aging continuum: Mechanistic geroscience, therapeutic innovation, and clinical impact},
  journal = {Ageing Research Reviews},
  year = {2026},
  doi = {10.1016/j.arr.2026.103205}
}
Kostenlos starten →